DNA Microarray Technology in Focus

---

In today's rapidly evolving scientific landscape, selecting the most appropriate technology to meet specific needs is crucial. At DNAPLUS Medic, we harness the power of a customized version of Illumina’s GSA microarray, a technology that stands out for its speed, affordability, and scalability. This approach enables the analysis of millions of genetic variations per patient in a single session, illustrating the importance of deploying the right technology for precise and efficient genetic examination.

DNA microarrays, also known as DNA chips or biochips, embody a pivotal technology in the study of gene expression and genotyping across vast genomic regions. This innovation has fundamentally transformed biological research, enabling scientists to concurrently analyze the expression of thousands of genes. Such capabilities are instrumental in dissecting the genetic foundations of diseases, particularly those involving multiple genes (polygenic disorders) and genetic determinants that influence drug efficacy (pharmacogenetics). This assay delineates the workings of DNA microarrays, their role in evaluating polygenic risk scores and pharmacogenetics, and the advantages they confer in these domains.

The essence of a DNA microarray lies in its structure: a small, solid platform, usually a glass slide or silicon chip, where DNA molecules are affixed in a meticulously arranged grid. Each grid spot harbors picomoles of specific DNA sequences, termed probes, engineered to hybridize with matching DNA or RNA sequences in the test sample. A typical assay involves labeling the sample DNA or RNA with a fluorescent dye to facilitate the detection and quantification of these hybridization events.

The procedure initiates with the extraction and labeling of nucleic acids from the sample. Following the application of these labeled extracts to the microarray, hybridization occurs. A scanner then identifies the fluorescent signals, which directly correlate with the volume of target nucleic acid interacting with each probe. Computational analyses are employed to interpret gene expression or genotyping patterns, shedding light on genetic activity across various conditions or individuals.

Employing DNA microarrays for analyzing polygenic risk scores and pharmacogenetics brings forth multiple advantages.